Biotest AG (BIO) | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Biotest AG

BRIEF

published on 07/01/2024 at 09:05, 4 months 20 days ago

Biotest AG Prepares Yimmugo Launch in the USA, Secures Strategic Deal with Kedrion

FDA Approval Biotest AG Yimmugo Kedrion Immunoglobulin
PRESS RELEASE

published on 07/01/2024 at 09:00, 4 months 20 days ago

Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
Biotest AG is set to launch its immunoglobulin Yimmugo in the USA with a strategic billion-dollar agreement with Kedrion, following FDA approval. The distribution deal aims to generate over $1 billion in revenue for Biotest

Biotest AG Yimmugo Immunoglobulin USA Market Launch Strategic Agreement
BRIEF

published on 06/24/2024 at 14:05, 4 months 27 days ago

Biotest's GoFuture Campaign Featured in Documentary "Future Seeds"

Sustainability Biotest AG GoFuture Future Seeds Eco-anxiety
PRESS RELEASE

published on 06/24/2024 at 14:00, 4 months 27 days ago

Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds'
Biotest AG's sustainability campaign GoFuture featured in the documentary 'Future Seeds', now available on Prime Video in twelve countries

Documentary Biotest AG GoFuture Future Seeds Sustainability Campaign
BRIEF

published on 06/17/2024 at 09:05, 5 months 4 days ago

Biotest Achieves Milestone with FDA Approval for Yimmugo

FDA Approval Yimmugo Biotest Immunodeficiencies Next Level Facility
PRESS RELEASE

published on 06/17/2024 at 09:00, 5 months 4 days ago

Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
Biotest AG achieves US approval for intravenous immunoglobulin Yimmugo, marking a significant milestone and future sales growth in the global market

Healthcare Innovation Biotest AG FDA Certification US Approval Immunoglobulin Yimmugo
BRIEF

published on 05/07/2024 at 20:31, 6 months 14 days ago

Biotest AG: Dividend Approval at Annual General Meeting

Annual General Meeting Shareholder Approval Dividend Distribution Preference Shares Biotest AG
PRESS RELEASE

published on 05/07/2024 at 20:26, 6 months 14 days ago

Biotest AG: Annual General Meeting approves dividend distribution
Biotest AG's Annual General Meeting approves dividend distribution of EUR 0.04 per preference share for 2023 and 2022, with majority support. CEO Peter Janssen's speech available online

Annual General Meeting Shareholders Dividend Distribution Biotest AG Peter Janssen
BRIEF

published on 05/07/2024 at 09:05, 6 months 14 days ago

Biotest AG Reports Significant Growth in Q1 2024

Revenue Growth Biotest AG Yimmugo Q1 2024 Financial Results Plasma Products
PRESS RELEASE

published on 05/07/2024 at 09:00, 6 months 14 days ago

Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024
Biotest AG reports a significant 83.6% increase in sales to Euro 215.2 million in the first quarter of 2024, driven by product sales and successful completion of the Fibrinogen study

EBIT Sales Increase Biotest AG First Quarter 2024 Fibrinogen Study

Accesswire

Published on 11/22/2024 at 00:00, 5 hours 50 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 45 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 35 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 40 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 10 hours 48 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 13 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 51 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 11 hours 58 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 11 hours 58 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 22 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 22 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE